Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.A Multicentre, Phase III Randomized Study by the PLRG.

NCT00801281 is registered in ClinicalTrials.gov with Polish Lymphoma Research Group as lead sponsor.

NCT NCT00801281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00801281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.A Multicentre, Phase III Randomized Study by the PLRG.
Lead sponsor
Polish Lymphoma Research Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
June 25, 2017
Enrollment
250 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma, small lymphocytic lymphoma